Pitch Deck
A 20-slide investor presentation covering the Autonomous Factory opportunity — problem, technology, traction, market, and the seed round ask. Available in full to waitlist members within 24 hours.
What is it?
A pitch deck is the primary document used to introduce the investment opportunity to potential investors. It presents the problem, the solution, the team, the market size, the traction, and the investment terms in a concise, structured format. The AxiForge deck is built to the standard expected by angel syndicates, SEIS/EIS funds, and seed-stage VCs — covering all layers of the Autonomous Factory thesis in 20 slides.
Why it matters
- The first document most investors request after initial contact
- Sets the narrative frame for all follow-up due diligence
- Communicates the IP and defensibility story clearly
- Quantifies the market opportunity and unit economics
- Presents the team and execution track record
- Establishes the valuation rationale and investment terms
The deck follows a standard investor narrative arc: establish the problem, present the solution and IP, demonstrate traction, quantify the market, and close with the ask.
Cover
AxiForge Holdings — Autonomous Factory seed round. Patent pending. Demonstrator live.
The Problem
Unplanned downtime costs SME manufacturers £3,000–£22,000 per hour. 79% experienced it in the last 3 years. No affordable solution exists for sub-enterprise scale.
Why Now
Three converging forces: Industry 4.0 cost curves, UK Made Smarter co-funding, and NHS Supply Chain Resilience Scoring creating first-mover advantage.
The Solution
Autonomous Factory — a fully proprietary stack: custom machinery, edge AI, and monitoring OS. Designed, built, and owned by AxiForge at every layer.
Product
Autonomous Factory OS — live dashboard screenshots, real-time sensor telemetry, predictive maintenance alerts, and production intelligence interface.
Technology Stack
Three proprietary layers: Engineering (hardware), Systems (edge AI + Sensor), Tech (software OS). No third-party dependency at any layer.
IP & Defensibility
UK patent pending on novel mechanical transmission system. Sensor firmware, Factory OS source code, and deployment methodology are trade secrets.
Traction
Demonstrator facility live and operational. Deskraft.pl autonomous furniture line producing and selling. First commercial client pipeline open.
Business Model
Three independent revenue paths: Technology Licensing (SaaS + deployment fees), Own Factories, Build-Operate-Sell. Each profitable on its own terms.
Market Size & Industry Demand
TAM: £4.2B (EU + UK SME manufacturing). SAM: £310M. SOM: £190k Y1 → £4.75M ARR Y5. 9 target sectors ranked by demand signal strength — IFR, Roland Berger, ONS, Make UK.
Go-to-Market
Phase 1: Poland + EU — live demonstrator driving direct sales. Phase 2: UK entry via Made Smarter. Phase 3: DE/CZ/SK OEM licensing.
Path 01 — Technology Licensing
Unit economics deep dive: deployment fee £80k–£200k, annual subscription £15k–£40k, gross margin 60–70% on software.
Path 02 — Own Autonomous Factories
Deskraft.pl: autonomous production, AI storefront, logistics, and customer service. Live reference eliminates the hardest B2B objection.
Path 03 — Build-Operate-Sell
UK medical needle manufacturing — no domestic producer, £70–75M/year NHS spend, 8–14× EBITDA exit multiple. First target facility.
Financial Projections & Exit Model
5-year revenue model: Conservative £20.6M / Base £50.7M / Optimistic £102.4M at Y5. Needle factory ramp to full NHS market (£72M). Exit valuation 14× EBITDA — Base case £497M at Y5. Precedent: MMT acquisition 13.7× EBITDA, Dec 2025.
Use of Funds
Seed allocation: 40% R&D, 30% Sales & Marketing, 20% Manufacturing, 10% Legal & Admin.
Team
Matthew Plodzien — CEO and founding engineer. Background, domain expertise, and execution track record.
Competitive Landscape
Why Siemens, ABB, and Fanuc do not serve this market. The SME gap — too fragmented for enterprise giants, too complex for off-the-shelf tools.
Investment Terms
SAFE instrument. Valuation cap £800,000. Discount 20%. Minimum £10,000. SEIS/EIS eligible. Liquidation preference 1× non-participating.
The Ask
Seed round target, use of proceeds, deployment milestones funded, and path to Series A.
Six arguments the deck is built to land — and that we expect investors to remember after a single read:
The market is real, large, and underserved
SME manufacturers across 4 sectors spend £4.2B per year on automation. Enterprise giants have no incentive to serve them — the market is too fragmented for their model. AxiForge enters where they cannot.
The technology is proprietary at every layer
Hardware, firmware, edge AI, and software OS are all built and owned by AxiForge. A UK patent is pending. Competitors who assemble third-party components cannot replicate the integrated stack.
The demonstrator eliminates the biggest objection
Autonomous Factory is not a concept — it is live and operational. Deskraft.pl produces and sells furniture without human labour intervention. Every month of operational data removes the risk of "unproven technology" from the investor calculus.
Three independent revenue paths, each self-standing
Technology Licensing scales like SaaS. Own Factories generate operating cash flow. Build-Operate-Sell produces high-multiple capital events. None of the three depends on the others to generate value.
The seed round buys 18 months and a first commercial client
The financial model is built bottom-up. Seed proceeds fund R&D, the first commercial deployment, and sales infrastructure. The path to ARR is defined, not assumed.
SEIS/EIS eligible — significant tax advantage for UK investors
UK-based investors can receive up to 50% income tax relief under SEIS and 30% under EIS. Advance assurance from HMRC is being sought. This materially reduces the effective risk of the investment.
Problem & Market
- Quantified cost of unplanned downtime in SME manufacturing
- Why the SME segment remains unserved by incumbent automation players
- TAM/SAM/SOM analysis across 4 target sectors
- Market timing: Made Smarter, NHS Supply Chain Resilience
Solution & Technology
- Three-layer proprietary stack: hardware, edge AI, software OS
- UK patent pending — mechanical transmission system
- Sensor SA-1 edge nodes: firmware and AI architecture
- Autonomous Factory OS: live dashboard and AI Advisor
Traction & IP
- Demonstrator facility: live operational data and throughput metrics
- Deskraft.pl: autonomous furniture line operating commercially
- First commercial client pipeline and sales status
- IP register: patent, trademarks, software copyright
The Ask
- Seed round size, SAFE terms, and valuation rationale
- Use of funds: R&D, sales, manufacturing, legal
- 18-month runway projection and deployment milestones
- SEIS/EIS eligibility and advance assurance timeline
Demand for autonomous factories and AI robotics is structural — driven by labour shortages, rising wages, and a manufacturing base deeply underserved by existing automation suppliers. Below are the 9 sectors Axiforge targets, ranked by demand signal strength. All figures from named sources.
74%
of UK mfg SMEs have no robot
MTC, 2025
104
robots/10k workers UK vs 177 global avg
IFR 2024
18→50%
highly automated today → by 2030
PwC, 2026
63%
of UK manufacturers plan robotics investment in 24 months
Make UK, 2024
Food & Beverage
AF + Robotics24,880 UK firms · 98.8% SMEs · cobot CAGR 29.1% EU
ONS/DEFRA 2024 · MarketDataForecast 2025
Pharmaceuticals & MedTech
AF + Robotics#1 fastest-growing automation sector · 65% plan PdM AI
Roland Berger 2026 · DHSC/DSIT 2024
Fabricated Metal Products
AF + Robotics~27,000 UK enterprises · robot installs +12% CAGR since 2018
ONS 2024 · IFR 2024 · MTC 2025
Electronics & Electrical
AF + Robotics129,000 robot units installed globally in 2024 — largest sector
IFR World Robotics 2025
Packaging
Robotics$40.9B market · ROI payback 18–24 months · CAGR 7.78%
Towards Packaging 2024
Automotive Supply Chain
Robotics2,500+ UK component suppliers · 40% workforce in SMEs
SMMT 2024
Plastics & Polymers
Robotics~5,800 UK enterprises · ~10% of global cobot demand
BPF · ForInsights 2024
Furniture & Wood Products
AF~9,000 UK firms · robot installs +63% YoY (CE Europe)
FIRA 2023 · IFR/Plastech 2024
Textiles & Apparel
AF~14,700 UK businesses · lowest automation penetration
ONS 2023 · UKFT
$3.38B
Global cobot market by 2030
CAGR 18.9%
MarketsandMarkets 2024
>42%
of SMEs adopting automation integrate cobots
SMEs = majority of cobot buyers
Emergen Research 2025
$119B
Dark factories (autonomous mfg) market 2024
CAGR 8.7% through 2030
Grand View Research
Revenue and exit are independent calculations. Revenue is the annual income the business generates. Exit value is the price a buyer would pay based on EBITDA — and the two figures coexist: a Base case exit of £497M does not mean the business stops generating £50.7M/year.
Annual Revenue Y1–Y5 · All Paths
| Year | Conservative | Base | Optimistic |
|---|---|---|---|
| Year 1 | £7.7M | £11.6M | £17.2M |
| Year 2 | £25.6M | £39.7M | £65.0M |
| Year 3Key | £37.2M | £63.4M | £103.9M |
| Year 4 | £51.7M | £85.3M | £152.5M |
| Year 5Key | £55.3M | £94.1M | £177.2M |
Path 03 — Needle Factory · NHS Market Capture
NHS spends £70–75M/year on needles sourced entirely from imports. Axiforge enters as sole UK domestic producer. Revenue grows as market share is captured.
Exit Valuation at Year 5 · 14× EBITDA
EBITDA margins by stream: deployment fees 30% · software subscriptions 75% · needle factory 28–38% · robotics monitoring 70%. Precedent: MMT acquisition 13.7× EBITDA, Dec 2025 (Scope Research M&A Database).
| Metric | Conservative | Base | Optimistic |
|---|---|---|---|
| Y5 Revenue | £55.3M | £94.1M | £177.2M |
| Blended EBITDA margin | 24% | 38% | 39% |
| EBITDA | £13.4M | £35.5M | £69.1M |
| Exit Value (14× EBITDA) | £187M | £497M | £967M |
Sources: IFR World Robotics 2025 · MTC 2025 · Make UK 2024 · PwC Industrial Mfg Outlook 2026 · Roland Berger Industrial Automation 2026 · NHS Supply Chain framework 2025 · Scope Research M&A Database (MMT 13.7× Dec 2025) · ONS Business Counts 2024 · Grand View Research · MarketsandMarkets.
Access the Full Pitch Deck
The complete 20-slide deck — including financial projections, product screenshots, and full investment terms — is delivered within 24 hours to waitlist members. Submit your details below.
Investor Perspective
The pitch deck is the document that opens the door. A strong deck does not close a round — but a weak one prevents it from opening. Investors receive hundreds of decks per year and make an initial judgement within the first three slides. The AxiForge deck is structured to answer the four questions every investor asks in sequence: Is the problem real? Is the solution defensible? Is the team capable? Are the numbers believable? The deck is available in full to waitlist members — a structure designed to qualify interest before sharing commercially sensitive projections.